000 01398 a2200385 4500
005 20250513002334.0
264 0 _c19801124
008 198011s 0 0 eng d
022 _a0002-9343
024 7 _a10.1016/0002-9343(80)90010-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarpenter, J R
245 0 0 _aProspective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine.
_h[electronic resource]
260 _bThe American journal of medicine
_cSep 1980
300 _a395-400 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies
_xanalysis
650 0 4 _aAntibodies, Antinuclear
_xanalysis
650 0 4 _aAntibody Formation
650 0 4 _aDNA
_ximmunology
650 0 4 _aDeoxyribonucleoproteins
_ximmunology
650 0 4 _aHumans
650 0 4 _aHydralazine
_xadverse effects
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aLupus Erythematosus, Systemic
_xchemically induced
650 0 4 _aNucleoproteins
_ximmunology
650 0 4 _aProspective Studies
700 1 _aMcDuffie, F C
700 1 _aSheps, S G
700 1 _aSpiekerman, R E
700 1 _aBrumfield, H
700 1 _aKing, R
773 0 _tThe American journal of medicine
_gvol. 69
_gno. 3
_gp. 395-400
856 4 0 _uhttps://doi.org/10.1016/0002-9343(80)90010-8
_zAvailable from publisher's website
999 _c6967837
_d6967837